Caitong International Asset Management Co., LTD Xenon Pharmaceuticals Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 905 shares of XENE stock, worth $26,760. This represents 0.02% of its overall portfolio holdings.
Number of Shares
905Holding current value
$26,760% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
70.1MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$170 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$136 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$112 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$98.3 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$91.3 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.84B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...